WHO recommends new cancer/hep C drugs, but not at any cost
This article was originally published in Scrip
Executive Summary
In what is being hailed as a groundbreaking event, the World Health Organization's has decided to add some of the newest drugs for cancer, hepatitis C and TB to its Essential Medicines List (EML).